Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14

Pharmacogenomics and Personalized Medicine


Archive: Volume 14, 2021

DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results

Martinez-Pinteño A, Rodriguez N, Blázquez A, Plana MT, Varela E, Gassó P, Lafuente A, Lazaro L, Mas S

Pharmacogenomics and Personalized Medicine 2021, 14:459-467

Published Date: 19 April 2021

CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment

Chen D, Xiong L, Zhang L, Yu H, Xu Y, Wang M, Jiang X, Xiong Z

Pharmacogenomics and Personalized Medicine 2021, 14:445-457

Published Date: 13 April 2021

CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy

Wu X, Dong W, Li H, Yang X, Jin Y, Zhang Z, Jiang Y

Pharmacogenomics and Personalized Medicine 2021, 14:417-430

Published Date: 9 April 2021

Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review

Maimaitiming J, Amuti G, TuHuTi A, Chen Y, Song XX, Wang J, Alimu A, Zhang K, Abudounaiyimu M, Jiang J, Wang XL, Guo YY

Pharmacogenomics and Personalized Medicine 2021, 14:409-416

Published Date: 7 April 2021

CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma

Sun J, Zhu X, Zhao Y, Zhou Q, Qi R, Liu H

Pharmacogenomics and Personalized Medicine 2021, 14:397-408

Published Date: 1 April 2021

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM

Pharmacogenomics and Personalized Medicine 2021, 14:395-396

Published Date: 31 March 2021

Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

El-Meligui YM, Abd Elrhman HE, Salahuddin A, Hamouda MA, Kassem AB

Pharmacogenomics and Personalized Medicine 2021, 14:381-393

Published Date: 30 March 2021

Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen

Zhu X, Zhu J, Sun F, Zhen Z, Zhou D, Lu S, Huang J, Que Y, Zhang L, Cai R, Wang J, Zhang Y

Pharmacogenomics and Personalized Medicine 2021, 14:369-377

Published Date: 23 March 2021

Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients

Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, Farcas M, Miclaus M Jnr, Popp R, Miclea D

Pharmacogenomics and Personalized Medicine 2021, 14:349-358

Published Date: 17 March 2021

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM

Pharmacogenomics and Personalized Medicine 2021, 14:335-347

Published Date: 16 March 2021

Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer

Pacini L, Jenks AD, Vyse S, Wilding CP, Arthur A, Huang PH

Pharmacogenomics and Personalized Medicine 2021, 14:301-317

Published Date: 9 March 2021

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions

Jeiziner C, Stäuble CK, Lampert ML, Hersberger KE, Meyer zu Schwabedissen HE

Pharmacogenomics and Personalized Medicine 2021, 14:279-286

Published Date: 19 February 2021

TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy

Song K, He F, Xin Y, Guan G, Huo J, Zhu Q, Fan N, Guo Y, Zang Y, Wu L

Pharmacogenomics and Personalized Medicine 2021, 14:269-278

Published Date: 16 February 2021

Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort

Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL

Pharmacogenomics and Personalized Medicine 2021, 14:239-252

Published Date: 15 February 2021

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study

Takahashi PY, Ryu E, Bielinski SJ, Hathcock M, Jenkins GD, Cerhan JR, Olson JE

Pharmacogenomics and Personalized Medicine 2021, 14:229-237

Published Date: 11 February 2021

Identification of Crucial Genes and Pathways Associated with Atherosclerotic Plaque in Diabetic Patients

Li YY, Zhang S, Wang H, Zhang SX, Xu T, Chen SW, Zhang Y, Chen Y

Pharmacogenomics and Personalized Medicine 2021, 14:211-220

Published Date: 4 February 2021

TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy

Rosdiana DS, Setiabudy R, Andalusia R, Gatot D, Louisa M, Bardosono S, Instiaty I

Pharmacogenomics and Personalized Medicine 2021, 14:199-210

Published Date: 3 February 2021

Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension

Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L

Pharmacogenomics and Personalized Medicine 2021, 14:189-197

Published Date: 2 February 2021

Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research

Wosiak A, Wodziński D, Michalska K, Pietrzak J, Kordek R, Balcerczak E

Pharmacogenomics and Personalized Medicine 2021, 14:167-178

Published Date: 29 January 2021

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients

Sokolik R, Iwaszko M, Świerkot J, Wysoczańska B, Korman L, Wiland P, Bogunia-Kubik K

Pharmacogenomics and Personalized Medicine 2021, 14:157-166

Published Date: 28 January 2021

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature

Salem M, Eljilany I, El-Bardissy A, Elewa H

Pharmacogenomics and Personalized Medicine 2021, 14:149-156

Published Date: 26 January 2021

CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations

Nizamuddin S, Dubey S, Singh S, Sharma S, Machha P, Thangaraj K

Pharmacogenomics and Personalized Medicine 2021, 14:135-147

Published Date: 27 January 2021

Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon

Fernandes MR, Rodrigues JCG, Maroñas O, Latorre-Pellicer A, Cruz R, Guerreiro JF, Burbano RMR, Assumpção PP, Ribeiro-dos-Santos A, Santos SEB, Carracedo A, Santos NPC

Pharmacogenomics and Personalized Medicine 2021, 14:117-133

Published Date: 22 January 2021

No Association Between FTO Gene Polymorphisms and Central Nervous System Tumor Susceptibility in Chinese Children

Liao Y, Yuan L, Zhang Z, Lin A, Zhou J, Zhuo Z, Zhao J

Pharmacogenomics and Personalized Medicine 2021, 14:109-115

Published Date: 19 January 2021

STAT6 rs324015 Gene Polymorphism Increases Ulcerative Colitis Risk: A Case–Control Study

Dai L, Zhang D, Qian Y, Wan Y, Chang S, Qian H

Pharmacogenomics and Personalized Medicine 2021, 14:101-107

Published Date: 19 January 2021

High LARGE1 Expression May Predict Benefit from Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer

Liu Y, Huang S, Kuang M, Wang H, Xie Q

Pharmacogenomics and Personalized Medicine 2021, 14:87-99

Published Date: 18 January 2021

Genetic Interaction of H19 and TGFBR1 Polymorphisms with Risk of Epilepsy in a Chinese Population

Zheng Z, Yan Y, Guo Q, Wang L, Han X, Liu S

Pharmacogenomics and Personalized Medicine 2021, 14:77-86

Published Date: 14 January 2021

Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions

Tong H, Phan NVT, Nguyen TT, Nguyen DV, Vo NS, Le L

Pharmacogenomics and Personalized Medicine 2021, 14:61-75

Published Date: 13 January 2021

Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer

Chuo D, Lin D, Yin M, Chen Y

Pharmacogenomics and Personalized Medicine 2021, 14:55-60

Published Date: 12 January 2021

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment

Yao Y, Zhang T, Qi L, Liu R, Liu G, Li J, Sun C

Pharmacogenomics and Personalized Medicine 2021, 14:15-26

Published Date: 8 January 2021

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin

Srisawasdi P, Rodcharoen P, Vanavanan S, Chittamma A, Sukasem C, Na nakorn C, Dejthevaporn C, Kroll MH

Pharmacogenomics and Personalized Medicine 2021, 14:1-13

Published Date: 6 January 2021